These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Characterizing brain tau and cognitive decline along the amyloid timeline in Alzheimer's disease. Cody KA; Langhough RE; Zammit MD; Clark L; Chin N; Christian BT; Betthauser TJ; Johnson SC Brain; 2024 Jun; 147(6):2144-2157. PubMed ID: 38667631 [TBL] [Abstract][Full Text] [Related]
23. Reference region selection and the association between the rate of amyloid accumulation over time and the baseline amyloid burden. Blautzik J; Brendel M; Sauerbeck J; Kotz S; Scheiwein F; Bartenstein P; Seibyl J; Rominger A; Eur J Nucl Med Mol Imaging; 2017 Aug; 44(8):1364-1374. PubMed ID: 28326436 [TBL] [Abstract][Full Text] [Related]
24. Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease From Other Neurodegenerative Disorders. Leuzy A; Smith R; Ossenkoppele R; Santillo A; Borroni E; Klein G; Ohlsson T; Jögi J; Palmqvist S; Mattsson-Carlgren N; Strandberg O; Stomrud E; Hansson O JAMA Neurol; 2020 Aug; 77(8):955-965. PubMed ID: 32391858 [TBL] [Abstract][Full Text] [Related]
26. The association between tau PET and retrospective cortical thinning in clinically normal elderly. LaPoint MR; Chhatwal JP; Sepulcre J; Johnson KA; Sperling RA; Schultz AP Neuroimage; 2017 Aug; 157():612-622. PubMed ID: 28545932 [TBL] [Abstract][Full Text] [Related]
27. 18F-flortaucipir PET to autopsy comparisons in Alzheimer's disease and other neurodegenerative diseases. Soleimani-Meigooni DN; Iaccarino L; La Joie R; Baker S; Bourakova V; Boxer AL; Edwards L; Eser R; Gorno-Tempini ML; Jagust WJ; Janabi M; Kramer JH; Lesman-Segev OH; Mellinger T; Miller BL; Pham J; Rosen HJ; Spina S; Seeley WW; Strom A; Grinberg LT; Rabinovici GD Brain; 2020 Dec; 143(11):3477-3494. PubMed ID: 33141172 [TBL] [Abstract][Full Text] [Related]
28. Sex modulates the ApoE ε4 effect on brain tau deposition measured by Liu M; Paranjpe MD; Zhou X; Duy PQ; Goyal MS; Benzinger TLS; Lu J; Wang R; Zhou Y Theranostics; 2019; 9(17):4959-4970. PubMed ID: 31410194 [TBL] [Abstract][Full Text] [Related]
29. Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease. Quiroz YT; Sperling RA; Norton DJ; Baena A; Arboleda-Velasquez JF; Cosio D; Schultz A; Lapoint M; Guzman-Velez E; Miller JB; Kim LA; Chen K; Tariot PN; Lopera F; Reiman EM; Johnson KA JAMA Neurol; 2018 May; 75(5):548-556. PubMed ID: 29435558 [TBL] [Abstract][Full Text] [Related]
30. Sex modifies APOE ε4 dose effect on brain tau deposition in cognitively impaired individuals. Yan S; Zheng C; Paranjpe MD; Li Y; Li W; Wang X; Benzinger TLS; Lu J; Zhou Y Brain; 2021 Nov; 144(10):3201-3211. PubMed ID: 33876815 [TBL] [Abstract][Full Text] [Related]
31. Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging. Ossenkoppele R; Smith R; Mattsson-Carlgren N; Groot C; Leuzy A; Strandberg O; Palmqvist S; Olsson T; Jögi J; Stormrud E; Cho H; Ryu YH; Choi JY; Boxer AL; Gorno-Tempini ML; Miller BL; Soleimani-Meigooni D; Iaccarino L; La Joie R; Baker S; Borroni E; Klein G; Pontecorvo MJ; Devous MD; Jagust WJ; Lyoo CH; Rabinovici GD; Hansson O JAMA Neurol; 2021 Aug; 78(8):961-971. PubMed ID: 34180956 [TBL] [Abstract][Full Text] [Related]
35. Compensating for choroid plexus based off-target signal in the hippocampus using Pawlik D; Leuzy A; Strandberg O; Smith R Neuroimage; 2020 Nov; 221():117193. PubMed ID: 32711062 [TBL] [Abstract][Full Text] [Related]
36. Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease. Maass A; Landau S; Baker SL; Horng A; Lockhart SN; La Joie R; Rabinovici GD; Jagust WJ; Neuroimage; 2017 Aug; 157():448-463. PubMed ID: 28587897 [TBL] [Abstract][Full Text] [Related]
37. Measurement of longitudinal β-amyloid change with 18F-florbetapir PET and standardized uptake value ratios. Landau SM; Fero A; Baker SL; Koeppe R; Mintun M; Chen K; Reiman EM; Jagust WJ J Nucl Med; 2015 Apr; 56(4):567-74. PubMed ID: 25745095 [TBL] [Abstract][Full Text] [Related]
38. Quantitative Zhao Q; Liu M; Ha L; Zhou Y; Front Neurol; 2019; 10():486. PubMed ID: 31156534 [TBL] [Abstract][Full Text] [Related]
39. Region-Specific Association of Subjective Cognitive Decline With Tauopathy Independent of Global β-Amyloid Burden. Buckley RF; Hanseeuw B; Schultz AP; Vannini P; Aghjayan SL; Properzi MJ; Jackson JD; Mormino EC; Rentz DM; Sperling RA; Johnson KA; Amariglio RE JAMA Neurol; 2017 Dec; 74(12):1455-1463. PubMed ID: 28973551 [TBL] [Abstract][Full Text] [Related]